Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 35,500 shares of Bluejay Diagnostics, Inc. ("Issuer") beneficially owned by Mr. Lichti, out of 708,533 shares of the Issuer's issued and outstanding shares of common stock, par value $0.0001 per share ("Common Stock") on January 29, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission ("Commission") on January 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 11,000 shares beneficially owned by Northstrive Fund II LP, out of 708,533 shares of the Issuer's issued and outstanding shares of Common Stock on January 29, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the Commission on January 27, 2026.


SCHEDULE 13G



 
Braeden Lichti
 
Signature:/s/ Braeden Lichti
Name/Title:Braeden Lichti
Date:02/05/2026
 
Northstrive Fund II LP
 
Signature:/s/ Braeden Lichti
Name/Title:Braeden Lichti, Manager
Date:02/05/2026